Sort
39,280 grants matching “leukemia”
Regulation And Function Of Retroelements
$1,080,876Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Adoptive T cell Therapy for Pediatric Leukemia
$1,080,868Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
$1,080,025Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R35 · FY2024 · HL
TET enzymes as guardians of genome stability
$1,080,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2017 · CA
DCTD Screening Technologies
$1,080,000Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA
TET enzymes as guardians of genome stability
$1,080,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2020 · CA
TET enzymes as guardians of genome stability
$1,080,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2018 · CA
TET enzymes as guardians of genome stability
$1,080,000Anjana Rao · La Jolla Institute For Immunology · R35 · FY2021 · CA
Eltrombopag for the Treatment of Fanconi Anemia
$1,079,663Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Mechanisms of nonsense-mediated mRNA decay target selection
$1,079,388John Hogg · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,079,030Sankar Adhya · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Cancer Prevention-Interception Against MGUS Progression
$1,078,336Yong Li · Baylor College Of Medicine · U54 · FY2024 · CA
Targeting High-Risk Lymphoid Neoplasms
$1,077,706David Marc Weinstock · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Synergistic role of signaling and epigenetics in leukemic transformation
$1,077,600Ross L Levine · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Marinobufagenin as a therapeutic target
$1,077,564Edward Lakatta · National Institute On Aging · ZIA · FY2024 · AG
Identifying the mechanisms of leukemia progression
$1,077,000John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2025 · CA
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,077,000Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2018 · CA
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,077,000Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2021 · CA
Identifying the mechanisms of leukemia progression
$1,077,000John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2021 · CA
Targeting Agents for Human and Canine Lymphoma
$1,076,270University Of California Davis · U19 · FY2005 · CA
PATHOGENESIS OF PERSISTENT VIRAL INJURY TO THE CNS
$1,075,071University Of Pennsylvania · P01 · FY2001 · NS
Immunobiology and immunotherapy of leukemia
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Characterization and improvement of graft versus leukemia effects
$1,074,460Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Hematopoietic Stem Cell Transplant for GATA2 Deficiency
$1,074,341Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
$1,074,143Amy J Powless · Cellia Science, Inc. · R44 · FY2025 · EB